Determining both lymphoid chimerism and the presence of minimal residual disease after
allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …

Chronic myeloid leukaemia (CML) can be treated successfully with allogeneic bone marrow
transplantation (BMT) leading to long-term disease-free survival. Leukemia relapse …

Serial cytogenetic studies were performed on 64 patients with chronic myelogenous
leukemia (CML) after T cell-depleted allogeneic bone marrow transplantation (BMT). Forty …

We have characterized mixed chimerism (MC) in five patients with chronic myeloid leukemia
(CML) who received transplants with T-cell—depleted bone marrow (BM) and who relapsed …

We studied lineage-specific chimerism and minimal residual disease (MRD) in sequential
posttransplant samples from 55 patients who underwent unmanipulated (n= 44) or partially T …

The kinetics of minimal residual disease (MRD) and chimerism were studied in 15 patients
with chronic myeloid leukemia (CML) receiving nonmyeloablative stem cell transplantation …

In the prospective study, we examined hematopoietic mixed chimerism (using polymerase
chain reaction (PCR) of variable number of tandem repeat-VNTR sequences) and minimal …

Using red cell phenotyping (RCP) and/or cytogenetics (CYT) we identified 19 patients with
persisting mixed chimerism (MC) among 231 patients transplanted with partially T cell …

Abstract Twenty-nine of 172 patients (17%) who received an allogeneic bone marrow
transplant (BMT) from histocompatible sibling donors for hematologic malignancies were …

The detection of chimerism, residual molecular and cytogenetic disease following
transplantation of peripheral blood stem cells (PBSCT) with a nonmyeloablative conditioning …